ES529108A0 - Procedimiento para la obtencion de derivados de la piridazina con accion psicotropa - Google Patents

Procedimiento para la obtencion de derivados de la piridazina con accion psicotropa

Info

Publication number
ES529108A0
ES529108A0 ES529108A ES529108A ES529108A0 ES 529108 A0 ES529108 A0 ES 529108A0 ES 529108 A ES529108 A ES 529108A ES 529108 A ES529108 A ES 529108A ES 529108 A0 ES529108 A0 ES 529108A0
Authority
ES
Spain
Prior art keywords
piridazine
derivatives
procedure
obtaining
psychotropic action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES529108A
Other languages
English (en)
Other versions
ES8500253A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8301366A external-priority patent/FR2540115B1/fr
Priority claimed from FR8318433A external-priority patent/FR2555178B1/fr
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of ES8500253A1 publication Critical patent/ES8500253A1/es
Publication of ES529108A0 publication Critical patent/ES529108A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES529108A 1983-01-28 1984-01-24 Procedimiento para la obtencion de derivados de la piridazina con accion psicotropa Granted ES529108A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8301366A FR2540115B1 (fr) 1983-01-28 1983-01-28 Derive de la pyridazine ayant une action psychotrope, son mode de preparation et les medicaments en contenant
FR8318433A FR2555178B1 (fr) 1983-11-18 1983-11-18 Derives cyanes de la pyridazine ayant une action psychotrope, leur mode de preparation et les medicaments en contenant

Publications (2)

Publication Number Publication Date
ES8500253A1 ES8500253A1 (es) 1984-10-01
ES529108A0 true ES529108A0 (es) 1984-10-01

Family

ID=26223263

Family Applications (1)

Application Number Title Priority Date Filing Date
ES529108A Granted ES529108A0 (es) 1983-01-28 1984-01-24 Procedimiento para la obtencion de derivados de la piridazina con accion psicotropa

Country Status (25)

Country Link
US (2) US4565814A (es)
EP (1) EP0116494B1 (es)
KR (1) KR910000639B1 (es)
AU (1) AU566352B2 (es)
CA (1) CA1218655A (es)
CS (1) CS274405B2 (es)
DD (1) DD215542A5 (es)
DE (1) DE3469026D1 (es)
DK (3) DK159969C (es)
ES (1) ES529108A0 (es)
FI (1) FI77453C (es)
GR (1) GR81682B (es)
HU (1) HU192975B (es)
IE (1) IE56750B1 (es)
IL (1) IL70755A (es)
MA (1) MA20019A1 (es)
NO (1) NO840329L (es)
NZ (1) NZ206957A (es)
OA (1) OA07645A (es)
PH (1) PH21476A (es)
PL (1) PL143994B1 (es)
PT (1) PT77994B (es)
SG (1) SG9389G (es)
SU (1) SU1274623A3 (es)
YU (1) YU14184A (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
DE3672536D1 (de) * 1985-06-14 1990-08-16 Lilly Co Eli Fungizide pyridazine.
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
NZ509748A (en) * 1998-08-20 2003-01-31 Toyama Chemical Co Ltd Nitrogenous heterocyclic carboxamide derivatives or salts useful as antiviral agents
EP1144388B1 (en) 1999-01-22 2010-01-13 Elan Pharmaceuticals, Inc. Acyl derivatives which treat vla-4 related disorders
TW200307671A (en) 2002-05-24 2003-12-16 Elan Pharm Inc Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
TWI281470B (en) 2002-05-24 2007-05-21 Elan Pharm Inc Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
CN1984904A (zh) * 2004-05-08 2007-06-20 神经能质公司 3－芳基－5,6－二取代哒嗪
EP1741709A1 (en) * 2005-06-28 2007-01-10 Sanofi-Aventis Deutschland GmbH Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
JP5081828B2 (ja) 2005-09-29 2012-11-28 エラン ファーマシューティカルズ，インコーポレイテッド Ｖｌａ−４によって媒介される白血球粘着を阻害するカルバメート化合物
NZ567270A (en) 2005-09-29 2011-06-30 Elan Pharm Inc Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4
KR20080100271A (ko) 2006-02-27 2008-11-14 엘란 파마슈티칼스, 인크. Ｖｌａ-4에 의해 매개되는 백혈구 부착을 억제하는 피리미디닐 술폰아미드 화합물
JP2012525336A (ja) 2009-04-27 2012-10-22 エラン ファーマシューティカルズ，インコーポレイテッド α−４インテグリンのピリジノンアンタゴニスト
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1345880A (en) * 1971-06-18 1974-02-06 Cepbepe Pyridazine derivatives
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2539739B1 (fr) * 1983-01-24 1985-11-22 Sanofi Sa Nouveaux derives de la naphtyl pyridazine actifs sur le systeme nerveux central, procede de preparation de ces derives et medicaments en contenant

Also Published As

Publication number Publication date
NZ206957A (en) 1987-06-30
DK162218C (da) 1992-03-02
OA07645A (fr) 1985-05-23
NO840329L (no) 1984-07-30
SG9389G (en) 1989-07-07
AU2372884A (en) 1984-08-02
HU192975B (en) 1987-08-28
KR910000639B1 (ko) 1991-01-31
YU14184A (en) 1986-10-31
DK621689D0 (da) 1989-12-08
DK621589D0 (da) 1989-12-08
IL70755A0 (en) 1984-04-30
GR81682B (es) 1984-12-12
US4565814A (en) 1986-01-21
FI77453B (fi) 1988-11-30
DK162218B (da) 1991-09-30
SU1274623A3 (ru) 1986-11-30
DK25984A (da) 1984-07-29
PL143994B1 (en) 1988-04-30
IL70755A (en) 1987-03-31
CA1218655A (en) 1987-03-03
DK621589A (da) 1989-12-08
PT77994A (fr) 1984-02-01
CS274405B2 (en) 1991-04-11
DK159969C (da) 1991-05-27
DK159969B (da) 1991-01-07
DE3469026D1 (en) 1988-03-03
FI840349A (fi) 1984-07-29
FI840349A0 (fi) 1984-01-27
PT77994B (fr) 1986-04-10
DK162219C (da) 1992-03-02
US4631280A (en) 1986-12-23
PH21476A (en) 1987-10-28
EP0116494B1 (fr) 1988-01-27
FI77453C (fi) 1989-03-10
IE840148L (en) 1984-07-28
PL245932A1 (en) 1985-05-21
MA20019A1 (fr) 1984-10-01
CS61484A2 (en) 1990-09-12
IE56750B1 (en) 1991-12-04
ES8500253A1 (es) 1984-10-01
DK621689A (da) 1989-12-08
DK162219B (da) 1991-09-30
DD215542A5 (de) 1984-11-14
EP0116494A1 (fr) 1984-08-22
DK25984D0 (da) 1984-01-20
AU566352B2 (en) 1987-10-15
KR840007587A (ko) 1984-12-08

Similar Documents

Publication Publication Date Title
ES537830A0 (es) Procedimiento para la obtencion de derivados de 5-amino-4-hidroxivalerilo sustituidos
ES555047A0 (es) Procedimiento para la obtencion de derivados de azolilmetil-ciclopropilcarbinol sustituido
ES529108A0 (es) Procedimiento para la obtencion de derivados de la piridazina con accion psicotropa
ES533538A0 (es) Procedimiento para la obtencion de tetrahidropiridazinonas
ES538172A0 (es) Procedimiento para la obtencion de derivados de etilendiamina sustituidos
ES542947A0 (es) Procedimiento para la obtencion de derivados piperazinicos
ES531103A0 (es) Procedimiento para la obtencion de benzofuranonas
ES552556A0 (es) Procedimiento para la obtencion de imidazoles sustituidos
ES529916A0 (es) Procedimiento para la obtencion de derivados de feniletilamina
ES526892A0 (es) Procedimiento para la obtencion de benzofuranonas
ES535704A0 (es) Procedimiento para la obtencion de derivados de piridinio
ES528654A0 (es) Procedimiento para la obtencion de derivados de tetrahidrocarbazol
ES533988A0 (es) Procedimiento para la obtencion de mercaptocarboxilamidas
ES527054A0 (es) Procedimiento para la obtencion de derivados bis-quinazolinicos
ES534947A0 (es) Procedimiento para la obtencion de 2-(1-indolinil-metil)-imidazolinas
ES549383A0 (es) Procedimiento para la obtencion de derivados de 2-aminometil-2-penem.
ES545599A0 (es) Procedimiento para la obtencion de derivados de ciclohexeno-na
ES537129A0 (es) Procedimiento para la obtencion de iodacetamidas
ES531837A0 (es) Procedimiento para la obtencion de derivados de azoliletil-bencil-eter.
ES510955A0 (es) Procedimiento para la obtencion de metilomelaminas monomeras
ES534035A0 (es) Procedimiento para la obtencion de teofilin-7-acetato de ambroxol
ES538833A0 (es) Procedimiento para la obtencion de derivados de iminometilazolilo
ES536665A0 (es) Procedimiento para la obtencion de derivados de azolil-tetrahidro-furan-2-iliden-metano sustituidos
ES529520A0 (es) Procedimiento para la obtencion de oximeteres sustituidos
ES527567A0 (es) Procedimiento para la obtencion de derivados de pirano-pirazol

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303